Luis Enrique Pizarro Maqueda
Directeur/Membre du Conseil chez Drugs for Neglected Diseases initiative
Profil
Luis Enrique Pizarro Maqueda is currently the Executive Director at Drugs for Neglected Diseases initiative since 2022.
Prior to this, he worked as the Director-Internal Audit at Abengoa SA from 2005 to 2013.
He completed his undergraduate degree from the University of Seville, graduate degree from Universidad Pablo de Olavide, and MBA from Instituto de Estudios Superiores de la Empresa.
Postes actifs de Luis Enrique Pizarro Maqueda
| Sociétés | Poste | Début |
|---|---|---|
Drugs for Neglected Diseases initiative
 Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Directeur/Membre du Conseil | 05/09/2022 |
Anciens postes connus de Luis Enrique Pizarro Maqueda
| Sociétés | Poste | Fin |
|---|---|---|
| ABENGOA, S.A. | Comptroller/Controller/Auditor | - |
Formation de Luis Enrique Pizarro Maqueda
| University of Seville | Undergraduate Degree |
| Instituto de Estudios Superiores de la Empresa | Masters Business Admin |
| Universidad Pablo de Olavide | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ABENGOA, S.A. | Industrial Services |
| Entreprise privées | 1 |
|---|---|
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Health Technology |
